Petra Cimflova
@PCimflova
Followers
206
Following
195
Media
12
Statuses
85
Neuroradiologist | Clinical researcher
Freiburg im Breisgau, Germany
Joined May 2020
Have you ever struggled with finding the true lumen of the dissected carotid or vertebral artery? 🧐 💡Check our bail out technique that is easy to use and may save your day / patients’ brain 🧠 https://t.co/P30JCFBPMF
1
15
68
Ever wondered how to do the stats for your first paper?🤔Don't you worry - We at @EYMINT_ESMINT got your back! The one and only @mihill68 talking about #statistics in #neurointervention for #earlycareer researchers! Part 1⃣ of a multi-part webinar series ➡️ https://t.co/BGMzwkE65C
esmint.eu
On Monday, 10 June 2024 from 5 PM - 6 PM CEST, we will have our third EYMINT Webinar Series on: Doing the stats for my first INR paper. The topic of part 3 is: Multivariable analysis.
1
9
31
Perforator aneurysms are rare and intriguing subtypes of intracranial aneurysms. Have you seen aneurysms of lenticulostriate, thalamo or basilar perforating arteries? join us: perfan@insel.ch @esmintsociety @SNISinfo @svinsociety @CheesemakerMD @DBervini @GoldbergJoh @Eikeip
0
22
57
New online @JNIS_BMJ: ⬇️mRS 0-2 in incomplete reperfusion than near complete reperfusion ⬇️ mRS 0–2 MT-accessible occlusion than non-MT-accessible occlusion pattern. ⬆️ patients with MT-accessible occlusion had infarcts than with non-MT occlusion pattern (68% vs46%).
0
6
13
In our recent study: Interaction between tortuosity, thrombus characteristics, and first-line EVT strategy: *Probability of FPE with contact aspiration⏬with higher tortuosity. *Longer thrombi were associated with⏫number of passes in the aspiration group https://t.co/ldkuYHymGa
journals.sagepub.com
Introduction: Despite improvements in device technology, only one-third of stroke patients undergoing endovascular thrombectomy (EVT) achieve first-pass effect ...
1
7
21
2/ Check out the article in #Stroke 👇 https://t.co/WtvYqeOe2H
@mihill68 @martha_marko @nimakashani @johanna_ospel @PCimflova @nishita_singh3 #AHAJournals
ahajournals.org
0
1
3
.@mayank_G0 and @rosevmcd recently spoke to @NN_publishing to discuss the "culture shift" they want to instigate through @collavidence - an "unconventional" start-up attempting to break down numerous longstanding barriers in #Stroke research https://t.co/mbiU7cxyQI
neuronewsinternational.com
Mayank Goyal and Rosalie McDonough (Calgary, Canada) discuss the pressing need Collavidence is hoping to address in global stroke research.
1
6
14
Proud CO-PI of this amazing project alongside my friend & CO-PI Dr Xunming Ji and all other BAOCHE investigators, Dr Chuanhui Li included. For the first time in BAO (and second time overall),the efficacy of EVT in the 6-24 hr window could be demonstrated.
nejm.org
The effects and risks of endovascular thrombectomy 6 to 24 hours after stroke onset due to basilar-artery occlusion have not been extensively studied. In a trial conducted over a 5-year period in C...
10
76
209
#MedTwitter - we‘d like to introduce the newest feature to the collavidence website! A space for our growing community to boost discussion and collaboration! Check out „Working groups“ on https://t.co/K0tNqpjpB7
#bettermedicinetogether #workinggroups
1
8
17
Dr. Rosalie McDonough @rosevmcd presenting collavidence to the acute stroke/ interventional community at the @5tStroke Conference at beautiful Banff @FairmontSprings 🇨🇦 Check out our website https://t.co/3WWN6Uiy4P
#bettermedicinetogether
1
4
21
Register now for the 5T Stroke Conference in the beautiful Banff Fairmont Springs 🇨🇦 (October 6 to 8, 2022) 🍁 Join us for the latest discussions on Acute Stroke treatment and care. Registration ✍️ & Agenda 🔖 at https://t.co/D3uCJrpHiB
1
10
30
Collavidence is at #SNIS2022 ✈️ Are you signed up yet? 🌎🌐 👉 https://t.co/3WWN6U0Xdh
#bettermedicinetogether #CommitToCure
@mayank_GO and @rosevmcd presents newly launched global platform connecting researchers, experts, patients, and donors 🌐 #SNIS2022 #NeuroTwitter @esmintsociety @cvsection @Doctorjfred @chriskellnerMD @JeremyHeitMDPHD
0
4
9
#MeVO is the next frontier in EVT!🚀But what are the desired qualities of EVT tools and barriers in #MeVO treatment?🤔We have asked!💡And here is what neurointerventionalists think about it!🌍 https://t.co/SlEqP34rp8
@NimaKashani @mayank_G0 @johanna_ospel @manonkappelhof @Fie0815
1
8
24
Several interesting projects have been uploaded to Collavidence. Have a look…🧠🔬 #stroketwitter #neurotwitter 👉 https://t.co/N2LWiuK4Uu 👉 https://t.co/H2qnG3dkBC
0
8
11
Take a look at this promising initiative! Help move stroke research forward together! #CommitToCure #stroke #recovery
Check out our #research project on @collavidence on brain reserve or whether brain frailty influences #stroke recovery irrespective of age 🔎🔋🪫🧠 Let us know what you think and help us reach our funding goal! $ 700✅ / 6000🏁 https://t.co/ff7gQTrbtE
0
3
5
A new tool for LVO detection developed in Calgary is here! We showed that StrokeSENS is reliable in identifying ICA and M1 MCA occlusions in timely manner! Read more here ➡️ https://t.co/tUPeMbHTkd
@Stroke_SENS @bijoymenon @johanna_ospel @KimBJstroke @manonkappelhof @FouziBala
2
7
25
🇨🇦 Calgary 🛫 Paris 🛬 Lyon 🇫🇷 Join Collavidence at #ESOC2022 Check out our e-posters (titles below) and don’t miss the presentation on Friday May 6, 9:42 AM, Scientific Session 27 #stroketwitter #neurotwitter
2
7
25
Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke (AcT) Trial: Protocol for a Pragmatic Registry linked Randomized Clinical Trial | Stroke: Vascular and Interventional Neurology https://t.co/n6EpH6xzDu
@SVINJournal @StrokeAHA_ASA @svinsociety
0
12
41